中国学者近期发表的论文
1.	Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP). Author: Lehuédé C1,2, Li X1,3, Dauvillier S1, Vaysse C1,4, Franchet C5, Clement E1, Esteve D1, Longué M6, Chaltiel L6, Le Gonidec S2, Lazar I1, Geneste A7, Dumontet C7, Valet P2, Nieto L1, Fallone F8, Muller C9. Journal: Breast Cancer Res. 2019 Jan 17;21(1):7. doi: 10.1186/s13058-018-1088-6.    PubMed      DOI
2.	Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies. Author: Xiao Y1, Xia J1, Li L2, Ke Y1, Cheng J1, Xie Y3, Chu W4, Cheung P5, Kim JH6, Colditz GA7, Tamimi RM8,9, Su X10. Journal: Breast Cancer Res. 2019 Jan 29;21(1):16. doi: 10.1186/s13058-019-1096-1.    PubMed      DOI
3.	A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling. Author: Wang DY1, Gendoo DMA2, Ben-David Y3,4, Woodgett JR5, Zacksenhaus E6,7. Journal: Breast Cancer Res. 2019 Jan 31;21(1):18. doi: 10.1186/s13058-019-1098-z.    PubMed      DOI
4.	AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Author: Cao W1,2, Li J2,3, Hao Q2, Vadgama JV4, Wu Y5. Journal: Breast Cancer Res. 2019 Feb 21;21(1):29. doi: 10.1186/s13058-019-1107-2.    PubMed      DOI
5.	Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Author: Wang Y1,2,3,4, Zeng J1,3, Wu W1,5, Xie S3,6, Yu H1,3, Li G1,3, Zhu T3,7, Li F1,3, Lu J1,3, Wang GY4,8, Xie X9,10,11, Zhang J12,13,14. Journal: Breast Cancer Res. 2019 May 17;21(1):64. doi: 10.1186/s13058-019-1150-z.    PubMed      DOI
6.	Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells. Author: Fan Y1,2,3,4, Si W1,2,3,4, Ji W1,2,3,4, Wang Z1,2,3,4, Gao Z1,2,3,4, Tian R1,2,3,4, Song W1,2,3,4, Zhang H1,2,3,4, Niu R5,6,7,8, Zhang F9,10,11,12. Journal: Breast Cancer Res. 2019 May 22;21(1):66. doi: 10.1186/s13058-019-1147-7.    PubMed      DOI
7.	Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Author: Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators, Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Nevanlinna H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R, Eeles R, Ellis S; EMBRACE, Hamann U, Garber J, Fostira F, Fountzilas G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen B, Hansen TV, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton DF, Chenevix-Trench G, Antoniou AC, Ottini L. Journal: Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y.    PubMed
8.	Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Author: Liu YR, Jiang YZ, Xu XE, Yu KD, Jin X, Hu X, Zuo WJ, Hao S, Wu J, Liu GY, Di GH, Li DQ, He XH, Hu WG, Shao ZM. Journal: Breast Cancer Res. 2016 Mar 15;18(1):33. doi: 10.1186/s13058-016-0690-8.    PubMed
9.	Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Author: Zhang F, Dong W, Zeng W, Zhang L, Zhang C, Qiu Y, Wang L, Yin X, Zhang C, Liang W. Journal: Breast Cancer Res. 2016 Apr 1;18(1):38. doi: 10.1186/s13058-016-0698-0.    PubMed
10.	Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients Author: liuxiaoan Journal: BREAST CANCER RESEARCH, 2016.

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 435.40 NEW ENGLAND JOURNAL OF MEDICINE 933 66.10 NATURE REVIEWS DRUG DISCOVERY 289 35.50 LANCET 700 73.40 Nature Reviews Clinical Oncology 127 37.50 NATURE REVIEWS CANCER 396 70.40 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 622 26.30 Nature Reviews Disease Primers 48 42.20 World Psychiatry 61 32.80 World Psychiatry 70 32.80

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 302561 CANCER RESEARCH 166757 Molecular Medicine Reports 165688 International Journal of Nanomedicine 165280 CANCER LETTERS 160437 JOURNAL OF ETHNOPHARMACOLOGY 142767 BIOMEDICINE & PHARMACOTHERAPY 142083 Theranostics 137055 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 136856 International Journal of Environmental Research and Public Health 134511